The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New portfolio company

2 Mar 2015 07:00

RNS Number : 1646G
Frontier IP Group plc
02 March 2015
 



 

 

AIM: FIPP

 

Frontier IP Group plc

("Frontier IP")

 

New Portfolio Company - Cambridge Sensor Technologies Ltd

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has received a stake in Cambridge Sensor Technologies Limited ("CST"), a company formed to exploit the technology developed by Dr. Mark Williamson, a lecturer and researcher at the Department of Chemical Engineering and Biotechnology at the University of Cambridge. Frontier IP has entered into an agreement with CST in which it has agreed to provide advisory and business development services in return for a 40% equity stake in the new company.

Dr. Williamson develops heating system, sensors and control strategies for industrial processes in which the composition of the processing atmosphere is important. The benefits of the technology include reduction in energy consumption and improvement/optimisation of the quality and consistency of the manufactured goods. A program of industrial trials is already underway, in collaboration with major multinational companies in the food and speciality chemicals sectors.

Neil Crabb, Chief Executive of Frontier IP, said,

"We are looking forward to working with Dr. Williamson on this new opportunity. Frontier IP brings experience in commercialising IP and relationships with key players in relevant markets. Dr. Williamson's industry-focused approach combined with our support can help accelerate the commercialisation for this exciting technology."

Enquiries

 

Frontier IP Group Plc

0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

Mark Percy / Catherine Leftley, Corporate Finance

David Banks, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

Lucy Williams

KTZ Communications

020 3178 6378

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IP Group plc www.frontierip.co.uk 

Frontier IP specialises in assisting universities, research institutions and companies in the commercialisation and exploitation of their Intellectual Property.

Department of Chemical Engineering and Biotechnology, University of Cambridge

The Department of Chemical Engineering and Biotechnology at the University of Cambridge is a leading global research department. It is ranked top for research in its discipline in the UK, best in the world outside the US and 4th in the world including the US (HEFCE REF 2014 and QS World University Rankings by Subject 2014). Working effectively with industry is a core strength of the Department, as is progressing novel technologies through spinout companies and licensing agreements to ultimate launch of marketed products.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUMUPUPAGRM
Date   Source Headline
26th Nov 20147:00 amRNSNew spin-out company
17th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20149:52 amRNSPortfolio company collaboration agreement
3rd Nov 20147:00 amRNSFundraising for portfolio company, Nandi
8th May 20147:00 amRNSBoard Changes
3rd Apr 20143:45 pmRNSHolding(s) in Company
2nd Apr 20147:00 amRNSDirector/PDMR Shareholding
31st Mar 20147:00 amRNSBoard appointments
31st Mar 20147:00 amRNSHalf Yearly Report
30th Dec 20139:46 amRNSHolding(s) in Company
23rd Dec 20139:51 amRNSHolding(s) in Company
20th Dec 20137:00 amRNSPlacing of New Shares
4th Dec 20132:50 pmRNSResult of AGM
4th Dec 20137:00 amRNSAGM Statement
18th Nov 20133:03 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSNew spin-out company with Plymouth University
12th Nov 20134:22 pmRNSHolding(s) in Company
8th Nov 20132:43 pmRNSNotice of AGM
6th Nov 20132:21 pmRNSHolding(s) in Company
31st Oct 20137:00 amRNSFinal Results
30th Sep 20137:00 amRNSTrading update & date of results
20th Aug 20137:00 amRNSHolding(s) in Company
20th Aug 20137:00 amRNSHolding(s) in Company
19th Aug 201310:57 amRNSHolding(s) in Company
16th Aug 201310:36 amRNSHolding(s) in Company
15th Aug 20134:14 pmRNSDirector/PDMR Shareholding
15th Aug 201312:01 pmRNSHolding(s) in Company
15th Aug 201312:00 pmRNSHolding(s) in Company
14th Aug 20137:00 amRNSPlacing, share swap, Director shareholdings & TVR
26th Jul 20137:00 amRNSEnergy Sector Collaboration
8th May 20137:00 amRNSRe Portfolio Company
2nd May 201312:00 pmRNSChange of Adviser
24th Apr 20137:00 amRNSRe Portfolio Company
23rd Apr 20137:00 amRNSRe Portfolio Company
28th Mar 20137:01 amRNSHalf Year Results
19th Mar 20138:37 amRNSHolding(s) in Company
14th Mar 20133:16 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSGrant of Options
31st Dec 201211:45 amRNSResult of AGM
11th Dec 20127:00 amRNSPortfolio Company - Tate & Lyle Contract
4th Dec 20124:23 pmRNSHolding(s) in Company
30th Nov 201212:43 pmRNSResult of General Meeting
6th Nov 20123:43 pmRNSCirc re. Conditional Placing
29th Oct 20127:00 amRNSPreliminary Results
26th Oct 20124:22 pmRNSAppointment of NOMAD & Broker
28th Sep 20127:00 amRNSHalf Year Results
28th Sep 20127:00 amRNSTrading Update
12th Jun 20127:00 amRNSProspective Fund Management Agreement
8th Jun 20127:00 amRNSNew Spin-out Company
23rd Mar 20127:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.